NewsUnited States of America

OpenEvidence Accelerates Growth With Bold Amaro Acquisition

Today, OpenEvidence made a significant move in the healthcare technology sector by announcing its acquisition of Amaro, an AI-native advertising startup. The deal comes as OpenEvidence continues to transform how clinicians access and use medical information.

OpenEvidence Acquires Amaro to Enhance AI Capabilities

OpenEvidence acquired Amaro, a company founded by Kush and Sauren Khosla and backed by Google Ventures. This acquisition aims to strengthen OpenEvidence’s expertise in AI-powered advertising automation. Amaro’s rapid development approach and technical excellence were highlighted as key factors in the decision. Both companies share a commitment to innovation and quality, making this partnership a strong strategic fit.

Amaro’s Technology to Boost Healthcare Advertising Models

With Amaro’s integration, OpenEvidence will expand its advertising infrastructure for healthcare professionals. The new capabilities are expected to help build a more modern, sustainable, and user-focused ad model. This move allows OpenEvidence to provide U.S. physicians with free access to crucial medical information, using an ad-supported platform to eliminate financial barriers for medical practices of all sizes.

OpenEvidence Accelerates Growth After Major Funding Round

The acquisition follows OpenEvidence’s recent $210 million Series B financing, which valued the company at an impressive $3.5 billion. Today, the platform supports over half a million clinical conversations daily and reaches more than 40% of U.S. physicians. The company also reports remarkable growth, adding 90,000 clinicians per month to its user base.

In summary, the OpenEvidence Amaro acquisition marks a pivotal step toward leading the medical AI platform market. By combining their technologies and expertise, the companies are set to accelerate growth and further empower clinicians with trusted, accessible information. The healthcare industry will be closely watching as this integrated team strives to redefine digital tools for medical professionals nationwide.

Don’t miss our latest Startup News: Radancy AI Platform Delivers Smarter, Faster Hiring Success

Photo of Andre

Andre

I am the Lead Editor at Startup World Tech, where I have dedicated over a decade to decoding the global startup ecosystem. With a degree in Journalism, I specialize in analyzing SaaS business models, Fintech regulations, and Artificial Intelligence ethics. My approach to tech journalism is hands-on. I don't just rewrite press releases; I report directly from the floor of industry shifts like CES, Web Summit, and VivaTech. My goal is to cut through the hype by conducting face-to-face interviews with founders and testing beta products in real-world scenarios before they hit the market.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button